Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247, Beijing YSCell Biotech Co., Ltd. [Abbreviated as YS])in Patients With Recurrent or Progressive

Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response

Personalized glioblastoma vaccine shows safety and survival promise in phase 1 trial

A phase 1 clinical trial at Siteman Cancer Center found that a personalized vaccine for glioblastoma, an aggressive brain cancer, is safe an

Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial

Programming the immunological properties of mRNA vaccines for cancer

AI-designed universal coronavirus vaccine shows promise in first human trial

University of Cambridge and DIOSynVax researchers have published results from the first human clinical trial of a universal coronavirus vacc